NET INCOME (LOSS) PER SHARE OF COMMON STOCK - Securities Excluded from Calculation of Weighted Average Shares Outstanding as their Effect is Antidilutive (Parenthetical) (Details) - shares |
6 Months Ended | |
|---|---|---|
Jun. 30, 2026 |
Dec. 31, 2025 |
|
| Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items] | ||
| Preferred stock, shares outstanding | 0 | 0 |
| Series A Preferred Stock | ||
| Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items] | ||
| Preferred stock, shares outstanding | 5,539 | |
| Conversion of stock converted | 2,619,947 | |
| Series A Preferred Stock | Tranche A Warrants | ||
| Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items] | ||
| Conversion of stock converted | 32,826,200 | |
| Issuance of common stock | 69,400 | |
| Series A Preferred Stock | Tranche B Warrants | ||
| Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items] | ||
| Conversion of stock converted | 18,920,000 | |
| Issuance of common stock | 40,000 |